Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene
- PMID: 11449320
- DOI: 10.1076/opge.22.2.107.2226
Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene
Abstract
Purpose: To describe the clinical phenotype in a family with Best's vitelliform macular dystrophy (BMD) and a new mutation (Val89Ala) in the VMD2 gene.
Methods: The genotype was determined by direct sequence analysis of the individual exons of VMD2. Nine members of a family with BMD were examined. The examination included best-corrected visual acuity, electro-oculography (EOG), fundus examination, and photography. Four of the patients were also examined with full-field ERG and three with multifocal ERG.
Results: A T-to-C substitution was identified at position 370 in the cDNA of VMD2, leading to a Val89Ala change in the protein. Six patients, five with the Val89Ala mutation and a nine-year-old boy without the mutation, presented with a pathological Arden ratio on EOG examination. Most of the patients with BMD in this family had an onset of visual failure by the age of 40-50 years. The older patients in the family demonstrated atrophic macular dystrophy.
Conclusions: Patients with BMD and the Val89Ala mutation in the VMD2 gene can present with a phenotype of a mostly late-onset visual failure. These BMD patients, who present with visual failure and macular degeneration in middle age, can be misdiagnosed as being affected with adult-onset macular dystrophies instead of BMD, because the latter is often regarded as a disease of childhood and adolescence.
Similar articles
-
Clinical expression of Best's vitelliform macular dystrophy in Swedish families with mutations in the bestrophin gene.Ophthalmic Genet. 1999 Dec;20(4):251-7. doi: 10.1076/opge.20.4.251.2270. Ophthalmic Genet. 1999. PMID: 10617923
-
Identification of a novel VMD2 mutation in Japanese patients with Best disease.Ophthalmic Genet. 2002 Jun;23(2):129-33. doi: 10.1076/opge.23.2.129.2213. Ophthalmic Genet. 2002. PMID: 12187431
-
Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy.Ophthalmology. 2001 Nov;108(11):2060-7. doi: 10.1016/s0161-6420(01)00777-1. Ophthalmology. 2001. PMID: 11713080
-
Best's vitelliform dystrophy.Ophthalmic Paediatr Genet. 1990 Mar;11(1):49-59. Ophthalmic Paediatr Genet. 1990. PMID: 2190134 Review.
-
VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies.Hum Mutat. 2000;15(4):301-8. doi: 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N. Hum Mutat. 2000. PMID: 10737974 Review.
Cited by
-
A comparison of pattern and multifocal electroretinography in the evaluation of age-related macular degeneration and its treatment with photodynamic therapy.Doc Ophthalmol. 2006 Sep;113(2):71-81. doi: 10.1007/s10633-006-9016-y. Epub 2006 Sep 14. Doc Ophthalmol. 2006. PMID: 16972084
-
Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.Int J Mol Sci. 2022 Jul 4;23(13):7432. doi: 10.3390/ijms23137432. Int J Mol Sci. 2022. PMID: 35806438 Free PMC article.
-
Clinical evaluation of two consanguineous families with homozygous mutations in BEST1.Mol Vis. 2011;17:1607-17. Epub 2011 Jun 16. Mol Vis. 2011. PMID: 21738390 Free PMC article.
-
[Function of bestrophin].Ophthalmologe. 2005 Feb;102(2):122-6. doi: 10.1007/s00347-004-1157-3. Ophthalmologe. 2005. PMID: 15627200 Review. German.
-
[Best's disease with normal EOG. Case report of familial macular dystrophy].Ophthalmologe. 2005 Sep;102(9):891-4. doi: 10.1007/s00347-004-1088-z. Ophthalmologe. 2005. PMID: 15657694 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases